JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

• Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder